lanadelumab (Takhzyro) Last Updated: September 19, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: lanadelumab Indications: Hereditary angioedema, prevention Brand Name: TakhzyroManufacturer: Shire Pharma Canada ULCProject Number: SR0618-000Project Status: ActiveSubmission Type: New Details
ustekinumab (Stelara/Stelara I.V) Last Updated: September 18, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: ustekinumab Indications: Ulcerative colitis Brand Name: Stelara/Stelara I.VManufacturer: Janssen Inc. Project Number: SR0627-000Project Status: ActiveSubmission Type: NewIndication Details
vortioxetine hydrobromide (Trintellix ) Last Updated: September 18, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: vortioxetine hydrobromide Indications: Major depressive disorder (MDD), adults. Brand Name: Trintellix Manufacturer: Lundbeck Canada Inc.Project Number: SR0611-000Project Status: ActiveSubmission Type: New Details
glycopyrrolate (Cuvposa) Last Updated: September 18, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: glycopyrrolate Indications: chronic severe drooling, neurologic (pediatric) Brand Name: CuvposaManufacturer: MEDEXUS Pharmaceuticals, Inc.Project Number: SR0613-000 Project Status: ActiveSubmission Type: New Details
belimumab (Benlysta ) Last Updated: September 19, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: Belimumab Indications: systemic lupus erythematosus Brand Name: Benlysta Manufacturer: GlaxoSmithKline Inc.Project Number: SR0616-000Project Status: ActiveSubmission Type: New Details
fluocinolone acetonide intravitreal implant (Iluvien) Last Updated: September 20, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: fluocinolone acetonide intravitreal implant Indications: diabetic macular edema Brand Name: IluvienManufacturer: Knight Therapeutics Inc.Project Number: SR0608-000Project Status: ActiveSubmission Type: New Details
onabotulinumtoxinA (Botox) Last Updated: September 18, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: onabotulinumtoxinA Indications: Migraine, chronic Brand Name: BotoxManufacturer: Allergan Canada Inc.Project Number: SR0584-000Project Status: ActiveSubmission Type: Resubmission Details
vedolizumab (Entyvio ) Last Updated: September 19, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: vedolizumab Indications: Ulcerative Colitis Brand Name: Entyvio Manufacturer: Takeda Canada Inc.Project Number: SR0635-000 Project Status: PendingSubmission Type: New Details
Keytruda Metastatic Urothelial Carcinoma (first line) – Details Last Updated: September 19, 2019 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10177 Details
Accelerated Resolution Therapy for Post-Traumatic Stress Disorder, Anxiety Disorders, or Mood Disorders: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last Updated: September 19, 2019 Result type: Reports Product Line: Rapid Response Research Type: Non-Pharma Mental Health Intervention Project Number: RB1404-000 Details
